What Statins Can’t Achieve: Failed AURORA Study Reinforces ESRD Doubts

It was foregone that the AURORA trial testing rosuvastatin in patients with advanced kidney disease on dialysis didn't work out; AstraZeneca noted it would no longer pursue the project during its 2008 year-end earnings call Jan. 28